For twenty-five years, professor Ruth Itzhaki’s research on microbes as a possible cause of Alzheimer’s diseases was dismissed and ridiculed. The idea that there could be a potential bridge between two starkly different fields–virology and neurodegeneration–seemed absurd at the time. Now, Itzhaki’s work is the backbone of an ongoing, cutting-edge trial on antiviral treatments for Alzheimer’s at Columbia University
Publisher
University of Illinois Undergraduate Neuroscience Society
Use this login method if you
don't
have an
@illinois.edu
email address.
(Oops, I do have one)
IDEALS migrated to a new platform on June 23, 2022. If you created
your account prior to this date, you will have to reset your password
using the forgot-password link below.
